Company · CIK 0001638097 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Entera Bio Ltd. · ENTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 AForm 4 → | Aug 7, 4:23 pm EDT | Steven D RubinDirector | 19,117 | — | — | 34,117 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:22 pm EDT | Yonatan MalcaDirector | 22,815 | — | — | 100,231 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:22 pm EDT | Haya TaitelDirector | 20,790 | — | — | 119,269 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:21 pm EDT | Sean EllisDirector | 20,034 | — | — | 208,132 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:18 pm EDT | Geno J GermanoDirector | 25,014 | — | — | 65,014 | — | |
| Jul 14, 2026 AForm 4 → | Jul 16, 4:05 pm EDT | Miranda Jayne ToledanoChief Executive Officer, Director | 420,560 | — | — | 847,135 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 AForm 4 → | Aug 7, 4:23 pm EDT | Steven D RubinDirector | 76,773 | — | — | 43,405 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:21 pm EDT | Sean EllisDirector | 40,000 | — | — | 40,000 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:20 pm EDT | Dana Yaacov-GarbeliChief Financial Officer | 140,000 | — | — | 140,000 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:19 pm EDT | Hillel GalitzerChief Operating Officer | 200,000 | — | — | 200,000 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:19 pm EDT | Gregory BurshteinChief of R&D | 180,000 | — | — | 180,000 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:19 pm EDT | Miranda Jayne ToledanoChief Executive Officer, Director | 700,000 | — | — | 200,000 | — | |
| Aug 7, 2026 AForm 4 → | Aug 7, 4:18 pm EDT | Geno J GermanoDirector | 93,014 | — | — | 43,014 | — |